FEIBA NF
FEIBA NF
Approved
DIN Number
02353903
Drug Class
Human
Market Date
Apr 4, 2011
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02353903
AIG Number0133136003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD03 FACTOR VIII INHIBITOR BYPASSING ACTIVITY
Product Specifications
Dosage FormKit
,
Powder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
ANTI-INHIBITOR COAGULANT COMPLEXActive
Strength: 3250 UNIT / VIAL
Monograph: ANTI-INHIBITOR COAGULANT COMPLEX